Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Samay Shivshankar, Josephine Nimely, Henry PuhlIIIIII & Malliga R. Iyer. (2024) Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor. International Journal of Molecular Sciences 25:9, pages 5012.
Crossref
Crossref
Chunhao Zhu, Xiaobing Lan, Zhiqiang Wei, Jianqiang Yu & Jian Zhang. (2024) Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain. Acta Pharmaceutica Sinica B 14:1, pages 67-86.
Crossref
Crossref
A. O. Shpakov. (2023) ALLOSTERIC SITES AND ALLOSTERIC REGULATORS OF G-PROTEIN-COUPLED RECEPTORS: GRAY CARDINALS OF SIGNAL TRANSDUCTION. Журнал эволюционной биохимии и физиологии 59:7, pages 559-658.
Crossref
Crossref
A. O. Shpakov. (2024) Allosteric Sites and Allosteric Regulators of G Protein-Coupled Receptors: Gray Cardinals of Signal Transduction. Journal of Evolutionary Biochemistry and Physiology 59:S1, pages S1-S106.
Crossref
Crossref
Alexander O. Shpakov. (2023) Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands. International Journal of Molecular Sciences 24:7, pages 6187.
Crossref
Crossref
María Gómez-Cañas, Carmen Rodríguez-Cueto, Valentina Satta, Inés Hernández-Fisac, Elisa Navarro & Javier Fernández-Ruiz. 2023. Endocannabinoid Signaling. Endocannabinoid Signaling
67
94
.
Candice B. Herber, Chaoshen Yuan, Anthony Chang, Jen-Chywan Wang, Isaac Cohen & Dale C. Leitman. (2022) 2′,3′,4′-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism. Molecular Medicine 28:1.
Crossref
Crossref
Mendhi Henna Dasram, Roderick B. Walker & Sandile M. Khamanga. (2022) Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery. International Journal of Molecular Sciences 23:21, pages 13223.
Crossref
Crossref
Asher L. Brandt, Sumanta Garai, Ayat Zagzoog, Dow P. Hurst, Lesley A. Stevenson, Roger G. Pertwee, Gregory H. Imler, Patricia H. Reggio, Ganesh A. Thakur & Robert B. Laprairie. (2022) Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593. Frontiers in Pharmacology 13.
Crossref
Crossref
Peter Obi & Senthil Natesan. (2022) Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs. Journal of Medicinal Chemistry 65:18, pages 12240-12255.
Crossref
Crossref
Sebastiaan Dalle, Moniek Schouten, Gitte Meeus, Lotte Slagmolen & Katrien Koppo. (2022) Molecular networks underlying cannabinoid signaling in skeletal muscle plasticity. Journal of Cellular Physiology 237:9, pages 3517-3540.
Crossref
Crossref
Dan L. McElroy, Andrew J. Roebuck, Quentin Greba, Sumanta Garai, Asher L. Brandt, Orhan Yilmaz, Stuart M. Cain, Terrance P. Snutch, Ganesh A. Thakur, Robert B. Laprairie & John G. Howland. (2022) The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg. IBRO Neuroscience Reports 12, pages 121-130.
Crossref
Crossref
Pierre‐Louis Raux, Guillaume Drutel, Jean‐Michel Revest & Monique Vallée. (2021) New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function. Journal of Neuroendocrinology 34:2.
Crossref
Crossref
Julien C. Dodu, Rebecca K. Moncayo, M. Imad Damaj, Joel E. Schlosburg, Hamid I. Akbarali, Lesley D. O’Brien, Debra A. Kendall, Zhixing Wu, Dai Lu & Aron H. Lichtman. (2022) The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice. Journal of Pharmacology and Experimental Therapeutics 380:1, pages 1-14.
Crossref
Crossref
Robert B. Laprairie. 2022. Allosteric Modulation of G Protein-Coupled Receptors. Allosteric Modulation of G Protein-Coupled Receptors
119
134
.
Thuy Nguyen, Thomas F. Gamage, Ann M. Decker, David B. Finlay, Tiffany L. Langston, Daniel Barrus, Michelle Glass, Danni L. Harris & Yanan Zhang. (2021) Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids. Bioorganic & Medicinal Chemistry 41, pages 116215.
Crossref
Crossref
Sumanta Garai, Luciana M. Leo, Anna-Maria Szczesniak, Dow P. Hurst, Peter C. Schaffer, Ayat Zagzoog, Tallan Black, Jeffrey R. Deschamps, Elke Miess, Stefan Schulz, David R. Janero, Alex Straiker, Roger G. Pertwee, Mary E. Abood, Melanie E. M. Kelly, Patricia H. Reggio, Robert B. Laprairie & Ganesh A. Thakur. (2021) Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy. Journal of Medicinal Chemistry 64:12, pages 8104-8126.
Crossref
Crossref
Catharine A. Mielnik, Vincent M. Lam & Ruth A. Ross. (2021) CB1 allosteric modulators and their therapeutic potential in CNS disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110163.
Crossref
Crossref
Francesca Gado, Kawthar A. Mohamed, Serena Meini, Rebecca Ferrisi, Simone Bertini, Maria Digiacomo, Felicia D’Andrea, Lesley A. Stevenson, Robert B. Laprairie, Roger G. Pertwee & Clementina Manera. (2021) Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor. European Journal of Medicinal Chemistry 211, pages 113116.
Crossref
Crossref
Beatrice Polini, Chiara Cervetto, Sara Carpi, Simone Pelassa, Francesca Gado, Rebecca Ferrisi, Simone Bertini, Paola Nieri, Manuela Marcoli & Clementina Manera. (2020) Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist. Life 10:12, pages 333.
Crossref
Crossref
Dongchen An, Steve Peigneur, Louise Antonia Hendrickx & Jan Tytgat. (2020) Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. International Journal of Molecular Sciences 21:14, pages 5064.
Crossref
Crossref
Marco Colizzi, Mirella Ruggeri & Sagnik Bhattacharyya. (2020) Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition. Frontiers in Psychology 11.
Crossref
Crossref
Richard A. Slivicki, Vishakh Iyer, Sonali S. Mali, Sumanta Garai, Ganesh A. Thakur, Jonathon D. Crystal & Andrea G. Hohmann. (2020) Positive Allosteric Modulation of CB1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward. Frontiers in Molecular Neuroscience 13.
Crossref
Crossref
Sumanta Garai, Pushkar M. Kulkarni, Peter C. Schaffer, Luciana M. Leo, Asher L. Brandt, Ayat Zagzoog, Tallan Black, Xiaoyan Lin, Dow P. Hurst, David R. Janero, Mary E. Abood, Anaelle Zimmowitch, Alex Straiker, Roger G. PertweeMelanie Kelly, Anna-Maria Szczesniak, Eileen M. Denovan-Wright, Ken Mackie, Andrea G. Hohmann, Patricia H. Reggio, Robert B. Laprairie & Ganesh A. Thakur. (2019) Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators. Journal of Medicinal Chemistry 63:2, pages 542-568.
Crossref
Crossref
Luigia Cristino, Tiziana Bisogno & Vincenzo Di Marzo. (2019) Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nature Reviews Neurology 16:1, pages 9-29.
Crossref
Crossref
Hryhorowicz, Kaczmarek-Ryś, Andrzejewska, Staszak, Hryhorowicz, Korcz & Słomski. (2019) Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities. International Journal of Molecular Sciences 20:23, pages 5874.
Crossref
Crossref
Thuy Nguyen, Thomas F. Gamage, Ann M. Decker, Daniel Barrus, Tiffany L. Langston, Jun-Xu Li, Brian F. Thomas & Yanan Zhang. (2019) Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators. Journal of Medicinal Chemistry 62:21, pages 9806-9823.
Crossref
Crossref
Chih-Chung TsengGemma Baillie, Giulia Donvito, Mohammed A. Mustafa, Sophie E. Juola, Chiara ZanatoChiara MassarentiSergio Dall’AngeloWilliam T. A. Harrison, Aron H. Lichtman, Ruth A. Ross, Matteo Zanda & Iain R. Greig. (2019)
The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB
1
Receptor Positive Allosteric Modulators
. Journal of Medicinal Chemistry 62:10, pages 5049-5062.
Crossref
Crossref
Estefanía Moreno, Milena Cavic, Ana Krivokuca, Vicent Casadó & Enric Canela. (2019) The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?. Frontiers in Pharmacology 10.
Crossref
Crossref
Thuy Nguyen, Thomas F. Gamage, Ann M. Decker, Nadezhda German, Tiffany L. Langston, Charlotte E. Farquhar, Terry P. Kenakin, Jenny L. Wiley, Brian F. Thomas & Yanan Zhang. (2018)
Diarylureas Containing 5-Membered Heterocycles as CB
1
Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation
. ACS Chemical Neuroscience 10:1, pages 518-527.
Crossref
Crossref
J. Daniel Lafreniere & Melanie E.M. Kelly. (2018) Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options. Neuronal Signaling 2:4.
Crossref
Crossref